Related Experiment Video
Updated: Apr 17, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Long-term prognosis and risk heterogeneity of heart failure complicating acute myocardial infarction
Leonardo P de Carvalho1, Fei Gao2, Qifeng Chen3
1National University Heart Centre, National University of Singapore, Singapore, Singapore; Albert Einstein Hospital, Sao Paulo, Brazil.
Insights
The Killip classification effectively predicts 12-year mortality in acute heart failure patients after myocardial infarction. Higher Killip classes indicate increased mortality risk, but class IV shows lower long-term risk than class III when early deaths are excluded.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- The Killip classification, established for acute myocardial infarction (AMI) short-term mortality, needed long-term prognostic validation.
- Acute heart failure is a critical complication of AMI, impacting patient outcomes.
Purpose of the Study:
- To evaluate the long-term (12-year) prognostic value of the Killip classification in unselected AMI patients.
- To analyze the relationship between Killip class and mortality over a decade post-hospitalization.
Main Methods:
- Retrospective cohort study of 15,235 patients hospitalized for AMI between 2000-2005.
- Vital status ascertained through national death records up to March 1, 2012.
- Statistical analysis using adjusted hazard ratios (HR) for mortality across Killip classes, including landmark analysis.
Main Results:
- A clear gradient of increasing 12-year mortality risk was observed with higher Killip classes (I-IV).
- Killip class IV showed a significantly higher adjusted HR for 12-year mortality (2.80) compared to class I.
- Landmark analysis revealed that Killip class IV patients had lower adjusted long-term mortality than class III, particularly in younger patients.
Conclusions:
- The Killip classification remains a robust predictor of long-term mortality following AMI.
- The study highlights the importance of early management for Killip class IV patients due to potential for improved long-term survival.
- Risk stratification using Killip class can guide clinical decisions and resource allocation for acute heart failure management.
Abstract:
The Killip classification of acute heart failure was developed decades ago to predict short-term mortality in patients with acute myocardial infarction (AMI). The aim of this study was to determine the long-term prognosis of acute heart failure graded according to the Killip classification in 15,235 unselected patients hospitalized for AMI from 2000 to 2005. Vital status for each patient was ascertained, through to March 1, 2012, from linkage with national death records. A stepwise gradient in the adjusted hazard ratio (HR) for 12-year mortality was observed with increasing Killip class: class I (n = 10,123), HR 1.00 (reference group); class II (n = 2,913), HR 1.13 (95% confidence interval [CI] 1.06 to 1.21); class III (n = 1,217) HR 1.49 (95% CI 1.37 to 1.62); and class IV (n = 898), HR 2.80 (95% CI 2.53 to 3.10). Unexpectedly, in a landmark analysis excluding deaths <30 days after admission, patients in Killip class IV had lower adjusted long-term mortality than those in class III. The adjusted HR for 12-year mortality comparing Killip class IV with Killip class III in patients <60 years of age was 1.71 (95% CI 1.33 to 2.19, p <0.001) and in patients >60 years of age was 2.30 (95% CI 2.07 to 2.56, p <0.001). In conclusion, on the basis of simple clinical features, the Killip classification robustly predicted 12-year mortality after AMI. The heterogeneity in early versus late risk in patients with Killip class IV heart failure underscores the importance of appropriate early treatment in cardiogenic shock.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure I: Introduction

